| Geld/Brief | 3,04 $ / 3,39 $ |
| Spread | +11,51% |
| Schluss Vortag | 3,14 $ |
| Gehandelte Stücke | 318.854 |
| Tagesvolumen Vortag | 816.677,6 $ |
| Tagestief 3,05 $ Tageshoch 3,16 $ | |
| 52W-Tief 2,675 $ 52W-Hoch 6,935 $ | |
| Jahrestief 2,675 $ Jahreshoch 4,825 $ | |
| Umsatz in Mio. | 4,63 $ |
| Operatives Ergebnis (EBIT) in Mio. | -208,35 $ |
| Jahresüberschuss in Mio. | -201,14 $ |
| Umsatz je Aktie | 0,03 $ |
| Gewinn je Aktie | -1,35 $ |
| Gewinnrendite | -4.342,44% |
| Umsatzrendite | -4.342,44% |
| Return on Investment | -58,69% |
| Marktkapitalisierung in Mio. | 569,52 $ |
| KGV (Kurs/Gewinn) | -2,57 |
| KBV (Kurs/Buchwert) | 4,28 |
| KUV (Kurs/Umsatz) | 115,67 |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +35,27% |
| Knock-Outs | 14 |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 3,12 $ | -1,42% | 3,165 $ | 18.09.26 | |
| Nasdaq | 3,12 $ | -0,64% | 3,14 $ | 18.09.26 | |
| NYSE | 3,105 $ | -0,80% | 3,13 $ | 18.09.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 18.09.26 | 3,12 | 0,82 M |
| 17.09.26 | 3,14 | 1,89 M |
| 16.09.26 | 3,00 | 2,22 M |
| 15.09.26 | 3,14 | 1,11 M |
| 14.09.26 | 3,18 | 0,63 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 3,13 $ | -0,32% |
| 1 Monat | 3,05 $ | +2,30% |
| 6 Monate | 3,53 $ | -11,61% |
| 1 Jahr | 5,12 $ | -39,06% |
| 5 Jahre | - | - |
| Marktkapitalisierung | 569,52 Mio. $ |
| Streubesitz | 19,67% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +8,45% | Alphabet Inc |
| +3,64% | T. Rowe Price Investment Management,Inc. |
| +2,58% | ARK Genomic Revolution ETF |
| +2,52% | BlackRock Inc |
| +2,48% | Vanguard Capital Management, LLC |
| +2,10% | FMR Inc |
| +2,03% | Vanguard Group Inc |
| +1,78% | State Street® SPDR® S&P® Biotech ETF |
| +1,73% | Vanguard Morn Total Stk Mkt Idx Investor |
| +1,73% | Balyasny Asset Management LLC |
| +1,72% | Vanguard MStar Total Stk Mkt Idx Invest |
| +1,67% | Vanguard Total Stock Mkt Idx Inv |
| +1,66% | Woodline Partners LP |
| +1,60% | UBS Group AG |
| +1,36% | T. Rowe Price Small-Cap Stock |
| +1,34% | T. Rowe Price Small-Cap Value |
| +1,30% | ARK Investment Management LLC |
| +1,27% | ARK Genomic Revolution |
| +1,19% | T. Rowe Price U.S. SC Value Eq Tr-D |
| +1,16% | Redmile Group, LLC |
| +1,09% | ADAR1 Capital Management LLC |
| +1,01% | MWG Management Ltd. |
| +0,99% | MWG Caph Ltd |
| +0,97% | The Goldman Sachs Group Inc |
| +0,90% | Two Sigma Investments LLC |
| +0,89% | Sumitomo Mitsui Trust Group Inc |
| +0,89% | Amova Asset Management Americas, Inc |
| +0,88% | Casdin Capital, LLC |
| +0,86% | D. E. Shaw & Co LP |
| +0,85% | Geode Capital Management, LLC |
| +0,80% | iShares Russell 2000 ETF |
| +0,79% | Millennium Management LLC |
| +0,70% | State Street Corp |
| +0,69% | T. Rowe Price Instl Small-Cap Stock |
| +0,68% | T. Rowe Price US Small-Cap Core Equity |
| +0,65% | Susquehanna International Group, LLP |
| +0,64% | Renaissance Technologies Corp |
| +0,58% | Amova ARK Pstv Chg Innovt P JPY Acc |
| +0,49% | T. Rowe Price U.S. SC Core Eq Tr-D |
| +0,47% | Greenwich Wealth Management LLC |
| +0,46% | Schonfeld Strategic Advisors LLC |
| +0,43% | ARK Venture D |
| +0,42% | Farallon Capital Management, L.L.C. |
| +0,4% | iShares Russell 2000 Growth ETF |
| +0,39% | BlackRock Advantage Small Cap Core Instl |
| +0,39% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,38% | Selectra J. Lamarck Biotech A |
| +0,35% | Russell 2000 Index Non-Lendable Fund |
| +0,34% | Russell 2000 Equity Index Fund B |
| +0,33% | Morgan Stanley - Brokerage Accounts |
| +0,33% | Fidelity Small Cap Index |
| +0,32% | iShares Biotechnology ETF |
| +0,31% | State St Russell Sm/Mid Cp® Indx SL Cl I |
| +0,29% | Citadel Advisors Llc |
| +0,29% | Charles Schwab Investment Management Inc |
| +0,29% | Northern Trust Corp |
| +0,28% | iShares Russell 2000 Value ETF |
| +0,28% | Wanjia Glb Growth IY Hold Alloc (QDII) A |
| +0,2% | Fidelity Extended Market Index |
| +0,17% | Schwab US Small-Cap ETF™ |
| +0,16% | Vanguard Russell 2000 ETF |
| +0,15% | Alger LIfe Sciences Innovation Composite |
| +0,12% | CREF Stock R3 |
| +62,708% | Institutionelle Aktionäre |
| +17,624% | Insider Aktionäre |
| +19,668% | Streubesitz |
